Zostavax Is Brand Name For Merck’s Herpes Zoster Vaccine
This article was originally published in The Pink Sheet Daily
Merck has chosen Zostavax as the brand name for its Phase III herpes zoster vaccine
You may also be interested in...
Gardasil's marketing model will be closer to a blockbuster pharmaceutical than to a traditional vaccine, CEO Gilmartin says. The company sees a parallel to the roll-out of Fosamax for osteoporosis.
The political spotlight on FDA during the COVID-19 pandemic has renewed the long-standing debate as to whether it should be made an independent, Cabinet-level federal agency and freed from direct HHS oversight.
The coronavirus pandemic highlights the work that is still needed on real-world evidence, agency's principal deputy commissioner says.